Peroxisome Proliferator Receptor alpha Agonist class drugs

5 results

  • antara

    (FENOFIBRATE)
    Lupin Pharmaceuticals, Inc.
    Antara is indicated as adjunctive therapy to diet for reducing triglyceride levels in adults with severe hypertriglyceridemia (≥500 mg/dL) and lowering LDL cholesterol in adults with primary hyperlipidemia when standard therapies are not possible. Its effect on pancreatitis risk and coronary heart disease outcomes is not established.
    Medication Details
    Drug Interactions

  • fenofibrate

    (fenofibrate)
    Chartwell RX, LLC.
    Fenofibrate capsules are indicated as adjunctive therapy to diet for reducing LDL-C, total cholesterol, triglycerides, and apo B in adults with primary hypercholesterolemia or mixed dyslipidemia (Types IIa and IIb), and for treating hypertriglyceridemia in adults (Types IV and V).
    Medication Details
    Drug Interactions

  • fenofibrate

    (fenofibrate)
    Mylan Pharmaceuticals Inc.
    Fenofibrate tablets are indicated as adjunctive therapy to diet for adults with primary hypercholesterolemia or mixed dyslipidemia, aiming to improve cholesterol levels. They are also used for treating severe hypertriglyceridemia, although their effect on reducing coronary heart disease risks in type 2 diabetes patients remains unproven.
    Medication Details
    Drug Interactions

  • fenofibrate

    (fenofibrate)
    Solco Healthcare US, LLC
    Fenofibrate tablets are indicated as adjunctive therapy to diet for adults with primary hypercholesterolemia, mixed dyslipidemia, or severe hypertriglyceridemia. They help reduce LDL-C, total cholesterol, triglycerides, and Apo B, while increasing HDL-C. They do not reduce coronary heart disease morbidity or mortality in diabetes patients.
    Medication Details
    Drug Interactions

  • pioglitazone and glimepiride

    (pioglitazone and glimepiride)
    Prasco Laboratories
    Pioglitazone and glimepiride tablets are indicated to improve glycemic control in adults with type 2 diabetes who are inadequately managed with a thiazolidinedione alone or sulfonylurea alone, combined with diet and exercise. Not for type 1 diabetes or diabetic ketoacidosis. Caution advised in liver disease.
    Medication Details
    Drug Interactions